Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Hematol Malig Rep. 2014 Mar;9(1):66-72. doi: 10.1007/s11899-013-0191-0.

Impact of the Affordable Care Act on stem cell transplantation.

Author information

1
Payor Policy, National Marrow Donor Program, 3001 Broadway Street, NE Suite 100, Minneapolis, MN, 55413, USA, sfarnia@nmdp.org.

Abstract

The Patient Protection and Affordable Care Act, signed into law in 2010, will have a wide-reaching impact on the health care system in the United States when it is fully implemented in 2014. Patients will see increased access to care coupled with new insurance coverage protections as well as a minimum set of benefits mandated in each state known as essential health benefits. Providers are likely to see new forms of payment reform, particularly in the Medicare program, and narrower commercial provider networks. In addition, the composition of the health insurance market will broaden with the introduction of health insurance exchanges and expanded Medicaid populations in many states. Furthermore, the Patient Protection and Affordable Care Act calls for quality initiatives such as comparative effectiveness research to increase effective, appropriate and high-value care. This paper will review the main provisions of the Patient Protection and Affordable Care Act with specific attention to their impact on the field of Stem Cell Transplantation.

PMID:
24398725
PMCID:
PMC3930843
DOI:
10.1007/s11899-013-0191-0
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center